Jaguar Health (JAGX) Preferred Shares (2018 - 2025)

Jaguar Health (JAGX) posted quarterly Preferred Shares of $2.5 million for Q4 2025, little changed quarter-over-quarter from $2.5 million in Q3 2025.

Jaguar Health (JAGX) Preferred Shares (2018 - 2025) Analysis & Trends

Jaguar Health (JAGX) has reported Preferred Shares for 4 consecutive years, with $2.5 million the latest figure, recorded in Q4 2025.

In Q4 2025, Preferred Shares changed N/A year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (changed N/A YoY), while the FY2025 annual figure was $2.5 million, changed N/A from the prior year.
Preferred Shares was little changed at $2.5 million in Q4 2025 per JAGX's latest filing, from $2.5 million in the prior quarter.
Across five years, Preferred Shares topped out at $2.5 million in Q2 2025 and bottomed at $2.5 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Jaguar Health	447,549.24	-9.62 Mn	19.11 Mn	-

Download Data